This inventor holds 3 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Inventor Dietmar Schöbel: Pioneering Triazole Compounds for Medical Innovation
Introduction
Dietmar Schöbel is a prominent inventor based in Mannheim, Germany, known for his contributions to pharmaceutical innovation through his work with triazole compounds. With three patents to his name, Schöbel has made significant strides in the field of medicinal chemistry, particularly in relation to dopamine-D3-receptor affinity.
Latest Patents
Among his most notable inventions is the patent for triazole compounds with high affinity for the dopamine-D3 receptor. This invention, described in detail in his patent applications, encompasses a formula where specific substituents (R, R, A, and B) play crucial roles in achieving the desired therapeutic effects. These compounds hold potential for treating various diseases that respond positively to dopamine-D3 ligands, showcasing Schöbel's dedication to advancing medical treatment options.
Career Highlights
Dietmar Schöbel currently works with Abbott Laboratories Corporation, where he applies his expertise to drive innovation in pharmaceutical development. His ongoing research focuses on enhancing the effectiveness of treatments aimed at diseases linked with dopamine receptors. Schöbel's ability to bridge scientific research with practical applications has positioned him as a key figure in his field.
Collaborations
Throughout his career, Schöbel has collaborated with notable colleagues such as Dorothea Starck and Hans-Jörg Treiber. These partnerships have been instrumental in the progression of his research and the successful development of his patented compounds, emphasizing the importance of teamwork in scientific advancement.
Conclusion
Dietmar Schöbel exemplifies the role of a modern inventor in the pharmaceutical industry. His innovative work on triazole compounds represents a significant contribution to medical science, offering hope for effective treatment options targeting dopamine-related diseases. Through his collaboration with esteemed colleagues and his tenure at Abbott Laboratories Corporation, Schöbel continues to pave the way for future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile